You are here

PV-10

The Emergence Of PV-10, And Provectus Biopharmaceuticals

Seeking Alpha

Wed, 01/21/15 - 11:51 am

immuno-oncology

Even If Provectus Successfully Markets PV-10 For Melanoma, It's Worth A Fraction Of The Current Stock Price

Seeking Alpha

Tue, 05/27/14 - 09:18 am

Provectus Biopharmaceuticals Inc. Reaffirms Its Commitment to Bringing PV-10 to Market Notwithstanding FDA Decision on Breakthrough Therapy Designation

Yahoo/BusinessWire

Sat, 05/24/14 - 09:54 am

Provectus Still Won't Answer Key Questions About Skin Cancer Drug PV-10

TheStreet.com

Fri, 01/24/14 - 12:08 pm

metastatic melanoma

Provectus Finds New Oncology Idea In An Old Product

Seeking Alpha

Tue, 10/1/13 - 10:08 am

Provectus Pharma treatment viewed positively by doctors

The Fly on the Wall

Mon, 04/16/12 - 11:27 am

metastatic melanoma